BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26318798)

  • 1. Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease.
    Wen Y; Zeng Z; Gui C; Li L; Li W
    Cardiovasc Pathol; 2015; 24(6):382-7. PubMed ID: 26318798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease.
    Bas HD; Baser K; Yavuz E; Bolayir HA; Yaman B; Unlu S; Cengel A; Bagriacik EU; Yalcin R
    J Investig Med; 2014 Jan; 62(1):78-83. PubMed ID: 24158043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial‑mesenchymal transition in the valvular damage due to rheumatic heart disease.
    Xian S; Chen A; Wu X; Lu C; Wu Y; Huang F; Zeng Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential involvement of S1PR1/STAT3 signaling pathway in cardiac valve damage due to rheumatic heart disease.
    Wu XD; Zeng ZY; Gong DP; Wen JL; Huang F
    Biotech Histochem; 2019 Aug; 94(6):398-403. PubMed ID: 30712389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and pathogenesis of rheumatic heart disease.
    Chopra P; Gulwani H
    Indian J Pathol Microbiol; 2007 Oct; 50(4):685-97. PubMed ID: 18306530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of mitral valve in Lewis rat with acute rheumatic heart disease.
    Li W; Zeng Z; Gui C; Zheng H; Huang W; Wei H; Gong D
    Int J Clin Exp Pathol; 2015; 8(11):14151-60. PubMed ID: 26823728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever/rheumatic heart disease.
    Sharma N; Toor D
    Cytokine; 2017 Feb; 90():169-176. PubMed ID: 27918954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternative technique for the induction of autoimmune valvulitis in a rat model of rheumatic heart disease.
    Gorton D; Blyth S; Gorton JG; Govan B; Ketheesan N
    J Immunol Methods; 2010 Apr; 355(1-2):80-5. PubMed ID: 20206182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Interleukin-13 in Patients with Rheumatic Valvular Fibrosis: A Clinical and Histological Study.
    Liu Q; Qiao WH; Li FF; Deng P; Hu ZW
    J Heart Valve Dis; 2015 Jul; 24(4):496-501. PubMed ID: 26897823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell subsets: an integral component in pathogenesis of rheumatic heart disease.
    Toor D; Sharma N
    Immunol Res; 2018 Feb; 66(1):18-30. PubMed ID: 29170852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of rheumatic fever and rheumatic heart disease.
    Guilherme L; Faé K; Oshiro SE; Kalil J
    Expert Rev Mol Med; 2005 Dec; 7(28):1-15. PubMed ID: 16336741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and local levels of fetuin-a in calcified mitral valves of rheumatic heart disease.
    Mukhopadhyay S; Pandit BN; Saran RK; Mazumdar K; Yusuf J; Minhas HS; Trehan V; Tyagi S
    J Heart Valve Dis; 2014 Jan; 23(1):55-65. PubMed ID: 24779329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple valve repair for rheumatic heart disease.
    Liuzzo JP; Shin YT; Lucariello R; Klapholz M; Lang SJ; Braff R; Guan H; Coppola JT; Ambrose JA
    J Card Surg; 2005; 20(4):358-63. PubMed ID: 15985139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever.
    Catarino SJ; Andrade FA; Boldt ABW; Guilherme L; Messias-Reason IJ
    Front Immunol; 2018; 9():3009. PubMed ID: 30619357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis].
    Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Guo SL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):751-6. PubMed ID: 22332535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions.
    Guilherme L; Faé KC; Oshiro SE; Tanaka AC; Pomerantzeff PM; Kalil J
    Ann N Y Acad Sci; 2005 Jun; 1051():132-40. PubMed ID: 16126952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients.
    Faé KC; Diefenbach da Silva D; Bilate AM; Tanaka AC; Pomerantzeff PM; Kiss MH; Silva CA; Cunha-Neto E; Kalil J; Guilherme L
    J Autoimmun; 2008 Sep; 31(2):136-41. PubMed ID: 18541406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies to polysaccharides of group A Streptococcus in patients with rheumatism after mitral commissurotomy].
    Sukharev AM; Kulemin VV; Borodiiuk NA; Dunaev GA; Isakova MI
    Ter Arkh; 1985; 57(8):118-21. PubMed ID: 3906993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role and mechanism of CD161
    Zhao W; Cheng H; Chen D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):296-301. PubMed ID: 31167687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.